Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

Wednesday, Nov 5, 2025 7:49 am ET1min read
OCUL--

Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet